News & Analysis on Clinical Trial Services & Contract Research And Development
Cardinal Health reported a varied first quarter, with sales and income receiving substantial gains due to across-the-board improvement in pharmaceutical distribution, medical products and services and clinical technologies.
The FDA is to extend its original review period for Exubera (insulin (rDNA origin) powder for oral inhalation) by three months to review additional technical chemistry data submitted by its producers.
Cryopak Industries has struck a deal to supply GlaxoSmithKline (GSK) with insulated containers and internal thermal components for shipping of its temperature sensitive vaccines in Canada.
Cambrex has recorded a gain in the third quarter of this year, with growth in its Bioproducts and Human Health segments. The company's troublesome BioPharma division continues to underperform, indicative of a market for outsourced manufacturing of...
Penn Pharmaceutical Services has reported strong sales figures for the fifth consecutive year, with a key driver of recent growth being attributed to a boom in contract manufacturing as well as small-scale commercial batches.